The purpose of this section is primarily to explore how insulin can be added to chemotherapy to treat gastrointestinal cancers, analyse and compare the effects of EVs and other methods combining EVs on gastrointestinal tumours and examine the novelty of EVs in treating gastrointestinal tumours in clinical settings. Here, INS is linked to digestive system neoplasm.